目的 分析遼寧省腫瘤醫(yī)院抗腫瘤藥物的使用情況,為臨床合理應(yīng)用抗腫瘤藥物提供參考。方法 對(duì)2012—2014年遼寧省腫瘤醫(yī)院抗腫瘤藥物的應(yīng)用種類、劑型、銷售金額進(jìn)行統(tǒng)計(jì)分析。結(jié)果 抗腫瘤藥物的銷售總金額呈逐年上升趨勢(shì),細(xì)胞毒類抗腫瘤藥物的銷售金額一直排名第1位;劑型中注射劑的構(gòu)成比一直居第1位;多西他賽、吉西他濱、來(lái)曲唑的銷售金額一直占據(jù)前3位。結(jié)論 臨床應(yīng)選擇適合的抗腫瘤藥物,提高患者生存率和生活質(zhì)量,促進(jìn)抗腫瘤藥物的合理應(yīng)用。

Objective To analyze the usage of anticancer drugs in Liaoning Cancer Hospital and Institute, and to provide reference for rational use of anticancer drugs. Methods The applied category, dosage form, and consumption sum of anticancer drugs in Liaoning Cancer Hospital and Institute from 2012 to 2014 were analyzed statistically. Results The consumption sum of the anticancer drugs increased year by year. Consumption sum of cytotoxic drugs ranked the first all the time. The constituent ratio of injections ranked the first all along. Consumption sum of docetaxel, gemcitabine, and letrozole were firmly at the top three. Conclusion Clinicians should select appropriate anticancer drugs, and improve survival and quality of life for patients, and promote the rational use of anticancer drugs.